MANCHESTER, England — Use of immunosuppressive drugs within 5 years of the onset of systemic sclerosis (SSc) did not lower patients’ risk for developing pulmonary arterial hypertension (PAH) but was associated with a significantly lower likelihood of death in patients with the complication, researchers reported at the British Society for Rheumatology (BSR) 2025 Annual Meeting. … Read more
Are you or a loved one struggling with the debilitating effects of pulmonary hypertension? Hope is on the horizon. New research explores the potential of pulmonary artery denervation (PADN) in treating this life-threating condition – offering a glimpse of a potential breakthrough in treating PH. Read on to learn about the promising results and what … Read more
A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for pulmonary hypertension (PH), a condition that places patients at risk for right heart failure and death. Co-authored by Dr. James Jenkins, … Read more
Close monitoring and individualizing treatment plans should be top priorities for the multidisciplinary teams caring for women who are pregnant or are considering pregnancy and exhibiting signs of pulmonary hypertension, according to new research published in International Journal of Cardiology Congenital Heart Disease.1 This patient population is known to have higher risks of maternal morbidity … Read more
Archyde Better Detection Needed for a Heart Warning Sign Table of Contents 1. Better Detection Needed for a Heart Warning Sign 2. researchers Find Variability in Echo Assessment of Heart Function in Pulmonary Hypertension Table of Contents 1. Better Detection Needed for a Heart Warning Sign 2. researchers Find Variability in Echo Assessment of Heart … Read more